Santini D - Search Results

1

Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment.

Fioramonti M, Fausti V, Pantano F, Iuliani M, Ribelli G, Lotti F, Pignochino Y, Grignani G, Santini D, Tonini G, Vincenzi B. Fioramonti M, et al. Among authors: santini d. Sci Rep. 2018 Mar 8;8(1):4177. doi: 10.1038/s41598-018-22469-5. Sci Rep. 2018. PMID: 29520051 Free PMC article.

2

Denosumab: the era of targeted therapies in bone metastatic diseases.

Santini D, Fratto ME, Vincenzi B, Napoli N, Galluzzo S, Tantardini M, Abbruzzese A, Caraglia M, Tonini G. Santini D, et al. Curr Cancer Drug Targets. 2009 Nov;9(7):834-42. doi: 10.2174/156800909789760375. Curr Cancer Drug Targets. 2009. PMID: 20025571 Review.

3

New molecular targets in bone metastases.

Santini D, Galluzzo S, Zoccoli A, Pantano F, Fratto ME, Vincenzi B, Lombardi L, Gucciardino C, Silvestris N, Riva E, Rizzo S, Russo A, Maiello E, Colucci G, Tonini G. Santini D, et al. Cancer Treat Rev. 2010 Nov;36 Suppl 3:S6-S10. doi: 10.1016/S0305-7372(10)70013-X. Cancer Treat Rev. 2010. PMID: 21129612 Review.

4

Procalcitonin as diagnostic marker of infection in solid tumors patients with fever.

Vincenzi B, Fioroni I, Pantano F, Angeletti S, Dicuonzo G, Zoccoli A, Santini D, Tonini G. Vincenzi B, et al. Among authors: santini d. Sci Rep. 2016 Jun 17;6:28090. doi: 10.1038/srep28090. Sci Rep. 2016. PMID: 27312877 Free PMC article.

5

Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review.

Cursano MC, Iuliani M, Casadei C, Stellato M, Tonini G, Paganelli G, Santini D, De Giorgi U. Cursano MC, et al. Among authors: santini d. Crit Rev Oncol Hematol. 2020 Feb;146:102864. doi: 10.1016/j.critrevonc.2020.102864. Epub 2020 Jan 7. Crit Rev Oncol Hematol. 2020. PMID: 31986318 Review.

6

Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer.

Cursano MC, Conteduca V, Scarpi E, Gurioli G, Casadei C, Gargiulo S, Altavilla A, Lolli C, Vincenzi B, Tonini G, Santini D, De Giorgi U. Cursano MC, et al. Among authors: santini d. Sci Rep. 2022 May 5;12(1):7319. doi: 10.1038/s41598-022-10751-6. Sci Rep. 2022. PMID: 35513478 Free PMC article.

7

A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss.

Santini D, Vincenzi B, Caraglia M, Tonini G. Santini D, et al. Ann Oncol. 2007 Jan;18(1):201-202. doi: 10.1093/annonc/mdl298. Epub 2006 Oct 4. Ann Oncol. 2007. PMID: 17021272 Free article. No abstract available.

8

New developments of aminobisphosphonates: the double face of Janus.

Santini D, Galluzzo S, Vincenzi B, Schiavon G, Fratto E, Pantano F, Tonini G. Santini D, et al. Ann Oncol. 2007 Jun;18 Suppl 6:vi164-7. doi: 10.1093/annonc/mdm249. Ann Oncol. 2007. PMID: 17591815 Free article. Review.

9

Potential role of everolimus in inducing cholestasis.

Pantano F, Santini D, Guida F, Vincenzi B, Tonini G. Pantano F, et al. Among authors: santini d. Ann Oncol. 2010 Feb;21(2):433. doi: 10.1093/annonc/mdp558. Epub 2009 Dec 2. Ann Oncol. 2010. PMID: 19955336 Free article. No abstract available.

10

Chemotherapy in biliary tract cancer.

Tonini G, Frato ME, Vincenzi B, Santini D. Tonini G, et al. Among authors: santini d. Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):371-4. Eur Rev Med Pharmacol Sci. 2010. PMID: 20496551 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,087 results

Search Page